You have searched for "malaria"
Showing 1-10 of 1880
LONDON/CHICAGO (Reuters) - The first wave of the COVID-19 pandemic may be waning. For vaccine developers, that could be a problem.
WASHINGTON (Reuters) - The United States has supplied Brazil with 2 million doses of hydroxychloroquine for use against the coronavirus, the two governments said on Sunday, despite medical warnings about risks associated with the anti-malaria drug.
PARIS (Reuters) - Sanofi
PETALING JAYA: It is only the new enrollment of patients for hydroxychloroquine treatment under the Covid-19 global trial that has been temporarily suspended, says the World Health Organisation (WHO) representative to Malaysia.
(Reuters) - Healthcare professionals should closely monitor COVID-19 patients receiving malaria drug hydroxychloroquine for serious side effects, the European health regulator said on Friday, stressing the need for in-depth clinical data on benefits and risks.
NEW YORK (Reuters) - U.S. hospitals said they have pulled way back on the use of hydroxychloroquine, the malaria drug touted by President Donald Trump as a COVID-19 treatment, after several studies suggested it is not effective and may pose significant risks.
JAKARTA (Reuters): Indonesia will continue to prescribe two anti-malaria drugs for coronavirus patients but monitor their use closely, a spokesman for Indonesia's Covid-19 taskforce said on Thursday (May 28), after some European nations banned the drug over safety concerns.
CHICAGO (Reuters) - Cancer patients with COVID-19 who were treated with a drug combination promoted by U.S. President Donald Trump to counter the coronavirus were three times more likely to die within 30 days than those who got either drug alone, U.S. researchers reported on Thursday.
Vaccines are one of the most important and effective methods of preventing potentially deadly infectious diseases from spreading among us.
PARIS/LONDON/MILAN (Reuters) - European governments moved on Wednesday to halt the use of anti-malaria drug hydroxychloroquine to treat COVID-19 patients, and a second global trial was suspended, further blows to hopes for a treatment promoted by U.S. President Donald Trump.